ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 183 filers reported holding ALKERMES PLC in Q3 2020. The put-call ratio across all filers is 9.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,366,320 | -6.8% | 3,475,694 | +4.2% | 0.01% | 0.0% |
| Q2 2023 | $104,430,696 | +16.7% | 3,336,443 | +5.1% | 0.01% | 0.0% |
| Q1 2023 | $89,476,048 | +112401.8% | 3,174,034 | +4.3% | 0.01% | +9.1% |
| Q4 2022 | $79,533 | -99.9% | 3,043,763 | +3.1% | 0.01% | +10.0% |
| Q3 2022 | $65,916,000 | -23.1% | 2,951,916 | +2.6% | 0.01% | -23.1% |
| Q2 2022 | $85,747,000 | +13.6% | 2,878,408 | +0.4% | 0.01% | +44.4% |
| Q1 2022 | $75,451,000 | +13.0% | 2,867,801 | -0.1% | 0.01% | +12.5% |
| Q4 2021 | $66,798,000 | -22.9% | 2,871,803 | +2.2% | 0.01% | -33.3% |
| Q3 2021 | $86,670,000 | +15.6% | 2,810,329 | -8.1% | 0.01% | +20.0% |
| Q2 2021 | $74,980,000 | +79.0% | 3,057,939 | +36.3% | 0.01% | +66.7% |
| Q1 2021 | $41,895,000 | +4.1% | 2,242,826 | +11.1% | 0.01% | -14.3% |
| Q4 2020 | $40,263,000 | +32.4% | 2,018,267 | +10.0% | 0.01% | +16.7% |
| Q3 2020 | $30,405,000 | -17.9% | 1,834,976 | -3.9% | 0.01% | -25.0% |
| Q2 2020 | $37,049,000 | +36.3% | 1,909,281 | +1.3% | 0.01% | +14.3% |
| Q1 2020 | $27,185,000 | -63.0% | 1,885,295 | -47.7% | 0.01% | -12.5% |
| Q4 2019 | $73,504,000 | +108.6% | 3,603,224 | +99.4% | 0.01% | 0.0% |
| Q3 2019 | $35,229,000 | -12.0% | 1,806,899 | +1.6% | 0.01% | -20.0% |
| Q2 2019 | $40,051,000 | -32.2% | 1,778,041 | +9.8% | 0.01% | -33.3% |
| Q1 2019 | $59,058,000 | -35.2% | 1,619,608 | -47.6% | 0.02% | +7.1% |
| Q4 2018 | $91,204,000 | +46.3% | 3,092,510 | +110.4% | 0.01% | -22.2% |
| Q3 2018 | $62,329,000 | +5.6% | 1,469,634 | +2.4% | 0.02% | 0.0% |
| Q2 2018 | $59,035,000 | -26.3% | 1,435,164 | +3.8% | 0.02% | -30.8% |
| Q1 2018 | $80,058,000 | +9.8% | 1,382,248 | +3.7% | 0.03% | +4.0% |
| Q4 2017 | $72,934,000 | +9.4% | 1,333,429 | +1.6% | 0.02% | 0.0% |
| Q3 2017 | $66,662,000 | -10.7% | 1,311,821 | +1.8% | 0.02% | -13.8% |
| Q2 2017 | $74,634,000 | +6.1% | 1,288,020 | +7.1% | 0.03% | 0.0% |
| Q1 2017 | $70,358,000 | +14.9% | 1,203,118 | +9.1% | 0.03% | +3.6% |
| Q4 2016 | $61,244,000 | +24.4% | 1,102,281 | +5.2% | 0.03% | +12.0% |
| Q3 2016 | $49,241,000 | +13.9% | 1,047,432 | +4.7% | 0.02% | +4.2% |
| Q2 2016 | $43,238,000 | +30.2% | 1,000,875 | +3.0% | 0.02% | +33.3% |
| Q1 2016 | $33,208,000 | -54.2% | 971,829 | +6.3% | 0.02% | -56.1% |
| Q4 2015 | $72,494,000 | +37.6% | 913,864 | +1.7% | 0.04% | +28.1% |
| Q3 2015 | $52,700,000 | -6.5% | 898,802 | +2.6% | 0.03% | 0.0% |
| Q2 2015 | $56,337,000 | +9.0% | 876,141 | +3.3% | 0.03% | +6.7% |
| Q1 2015 | $51,692,000 | +11.2% | 848,269 | +6.9% | 0.03% | +7.1% |
| Q4 2014 | $46,475,000 | +33.2% | 793,637 | -2.5% | 0.03% | +21.7% |
| Q3 2014 | $34,885,000 | -9.1% | 813,748 | +6.7% | 0.02% | -8.0% |
| Q2 2014 | $38,373,000 | +18.3% | 762,435 | +3.6% | 0.02% | +13.6% |
| Q1 2014 | $32,439,000 | +22.0% | 735,764 | +12.5% | 0.02% | +22.2% |
| Q4 2013 | $26,585,000 | +29.4% | 653,859 | +7.0% | 0.02% | +12.5% |
| Q3 2013 | $20,552,000 | +20.6% | 611,294 | +2.9% | 0.02% | +6.7% |
| Q2 2013 | $17,038,000 | – | 594,060 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |